Duality Biotherapeutics Sets 24–29 April 2026 Book Closure for Extraordinary General Meeting

Bulletin Express

04/09

Duality Biotherapeutics, Inc. will convene an Extraordinary General Meeting (EGM) at 9:00 a.m. on Wednesday, 29 April 2026, in the Board Room, 11/F, Building A, No. 868 Yinghua Road, Pudong New Area, Shanghai, PRC.

The company’s register of members will be closed from Friday, 24 April 2026 to Wednesday, 29 April 2026 (both days inclusive). During this period, no share transfers will be registered. Shareholders wishing to qualify for attendance and voting must lodge share transfer documents with Computershare Hong Kong Investor Services Limited (Shops 1712-1716, 17/F, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong) by 4:30 p.m. on Thursday, 23 April 2026.

A circular, notice of the EGM and related proxy form will be dispatched to shareholders in due course.

The Board currently comprises three executive directors (Dr. Zhu Zhongyuan, Mr. Zhang Shaoren, Dr. Hua Haiqing), two non-executive directors (Mr. Cai Zhiyang, Dr. Yu Tao) and three independent non-executive directors (Mr. Xie Dong, Mr. Gao Fengyong, Ms. Chuai Shuyin).

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1172387094"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1172387094\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1172387094?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-09 16:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1172387094","market":"us","top_or_hot":-1,"title":"Duality Biotherapeutics Sets 24–29 April 2026 Book Closure for Extraordinary General Meeting","media":"Bulletin Express","content":"<p>Duality Biotherapeutics, Inc. will convene an Extraordinary General Meeting (EGM) at 9:00 a.m. on Wednesday, 29 April 2026, in the Board Room, 11/F, Building A, No. 868 Yinghua Road, Pudong New Area, Shanghai, PRC.</p>\n<p>The company’s register of members will be closed from Friday, 24 April 2026 to Wednesday, 29 April 2026 (both days inclusive). During this period, no share transfers will be registered. Shareholders wishing to qualify for attendance and voting must lodge share transfer documents with Computershare Hong Kong Investor Services Limited (Shops 1712-1716, 17/F, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong) by 4:30 p.m. on Thursday, 23 April 2026.</p>\n<p>A circular, notice of the EGM and related proxy form will be dispatched to shareholders in due course.</p>\n<p>The Board currently comprises three executive directors (Dr. Zhu Zhongyuan, Mr. Zhang Shaoren, Dr. Hua Haiqing), two non-executive directors (Mr. Cai Zhiyang, Dr. Yu Tao) and three independent non-executive directors (Mr. Xie Dong, Mr. Gao Fengyong, Ms. Chuai Shuyin).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Duality Biotherapeutics Sets 24–29 April 2026 Book Closure for Extraordinary General Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDuality Biotherapeutics Sets 24–29 April 2026 Book Closure for Extraordinary General Meeting\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-04-09 16:41</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Duality Biotherapeutics, Inc. will convene an Extraordinary General Meeting (EGM) at 9:00 a.m. on Wednesday, 29 April 2026, in the Board Room, 11/F, Building A, No. 868 Yinghua Road, Pudong New Area, Shanghai, PRC.</p>\n<p>The company’s register of members will be closed from Friday, 24 April 2026 to Wednesday, 29 April 2026 (both days inclusive). During this period, no share transfers will be registered. Shareholders wishing to qualify for attendance and voting must lodge share transfer documents with Computershare Hong Kong Investor Services Limited (Shops 1712-1716, 17/F, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong) by 4:30 p.m. on Thursday, 23 April 2026.</p>\n<p>A circular, notice of the EGM and related proxy form will be dispatched to shareholders in due course.</p>\n<p>The Board currently comprises three executive directors (Dr. Zhu Zhongyuan, Mr. Zhang Shaoren, Dr. Hua Haiqing), two non-executive directors (Mr. Cai Zhiyang, Dr. Yu Tao) and three independent non-executive directors (Mr. Xie Dong, Mr. Gao Fengyong, Ms. Chuai Shuyin).</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09606","symbol_name":"映恩生物-B","start_time":0,"source_url":"","article_id":"1172387094","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1172387094","pubTimestamp":1775724115,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Duality Biotherapeutics, Inc. will convene an Extraordinary General Meeting (EGM) at 9:00 a.m. on Wednesday, 29 April 2026, in the Board Room, 11/F, Building A, No. 868 Yinghua Road, Pudong New Area,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09606":"映恩生物-B"},"translate_title":"Duality Biotherapeutics定于2026年4月24日至29日举行特别股东大会截止登记","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09606":1},"content_text":"Duality Biotherapeutics, Inc. will convene an Extraordinary General Meeting (EGM) at 9:00 a.m. on Wednesday, 29 April 2026, in the Board Room, 11/F, Building A, No. 868 Yinghua Road, Pudong New Area, Shanghai, PRC.\nThe company’s register of members will be closed from Friday, 24 April 2026 to Wednesday, 29 April 2026 (both days inclusive). During this period, no share transfers will be registered. Shareholders wishing to qualify for attendance and voting must lodge share transfer documents with Computershare Hong Kong Investor Services Limited (Shops 1712-1716, 17/F, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong) by 4:30 p.m. on Thursday, 23 April 2026.\nA circular, notice of the EGM and related proxy form will be dispatched to shareholders in due course.\nThe Board currently comprises three executive directors (Dr. Zhu Zhongyuan, Mr. Zhang Shaoren, Dr. Hua Haiqing), two non-executive directors (Mr. Cai Zhiyang, Dr. Yu Tao) and three independent non-executive directors (Mr. Xie Dong, Mr. Gao Fengyong, Ms. Chuai Shuyin).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}